OraSure Technologies | OSUR - 营业利润



金融业
股票价格
USD
资产
USD 360.55M
现金及等价物
USD 160.58M
销售成本
USD 15.43M
流动资产
USD 222.94M
流动负债
USD 25.12M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 317.78M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 282.6M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.07M
贸易债权人
USD 8.4M
应收帐款人
USD 22.2M


营业利润 更改 日
Agilent USD 444M 45M 2026-06
AngioDynamics USD -2.51M 5.41M 2025-09
Becton, Dickinson and Co. USD 752M 125M 2026-06
Bio Techne USD 75.49M 21.03M 2026-03
Bio-Rad Laboratories USD 72.6M 38.5M 2026-06
Bruker USD 69.6M 59.4M 2026-06
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 119.89M 9K 2026-06
Danaher USD 1.13B 217M 2026-06
Dentsply International USD 84M 52M 2026-06
Dexcom USD 318.3M 63M 2026-06
Illumina USD 260M 21M 2026-06
Integra LifeSciences USD 41.29M 29.82M 2026-06
Intuitive Surgical USD 977.6M 117.9M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Mesa Laboratories USD 5.78M 2.27M 2024-12
Mettler Toledo International USD 287.55M 53.61M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Quidel USD -15.3M 16.5M 2026-06
Repligen USD 21.13M 1.15M 2026-06
Revvity USD 126.14M 43.36M 2026-06
STAAR Surgical USD 10.1M 7.3M 2026-06
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Trinity Biotech USD -1.3M 796K 2025-12
Waters USD -86M 234M 2026-06